-
Trastuzumab, sold
under the
brand name
Herceptin among others, is a
monoclonal antibody used to
treat breast cancer and
stomach cancer. It is specifically...
-
Trastuzumab emtansine, sold
under the
brand name Kadcyla, is an antibody-drug
conjugate consisting of the
humanized monoclonal antibody trastuzumab (Herceptin)...
-
Trastuzumab deruxtecan, sold
under the
brand name Enhertu, is an antibody-drug
conjugate consisting of the
humanized monoclonal antibody trastuzumab (Herceptin)...
- Pertuzumab/
trastuzumab/hyaluronidase, sold
under the
brand name Phesgo, is a fixed-dose
combination medication to
treat adults with HER2-positive breast...
-
antibody trastuzumab (marketed as Herceptin).
Trastuzumab is
effective only in
cancers where HER2 is over-expressed. One year of
trastuzumab therapy is...
- system.
Examples of such
antibodies include rituximab (targeting CD-20),
trastuzumab (targeting HER-2), and
cetuximab (targeting EGFR).[citation needed] P****ive...
-
brand name Perjeta, is a
monoclonal antibody used in
combination with
trastuzumab and
docetaxel for the
treatment of
metastatic HER2-positive
breast cancer;...
- 2021.
Tucatinib is a
kinase inhibitor indicated in
combination with
trastuzumab and
capecitabine for the
treatment of
adults with
advanced unresectable...
-
create an antibody-drug
conjugate (ADC). ADCs with this
design include trastuzumab emtansine,
lorvotuzumab mertansine, and
cantuzumab mertansine. Some are...
-
Isatuximab L01FD01
Trastuzumab L01FD02
Pertuzumab L01FD03
Trastuzumab emtansine L01FD04
Trastuzumab deruxtecan L01FD05
Trastuzumab duocarmazine L01FD06...
